Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Luczkowska K, Stekelenburg C, Sloan-Bna F, et al
The last dividend per share was 1.73 USD
A combination of limited access and high popularity drives the expense
Activation of mammalian target of rapamycin controls the loss of TCR in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation
Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
US$ 25.04
US$ 29.63
US$ 23.02
US$ 23.15
US$ 23.32
US$ 26.43
US$ 27.40
US$ 27.47
